Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katharine Floyd

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron VariantRajesh M Valanparambil, Jennifer Carlisle, Susanne L Linderman, et al.
Science Immunology|July 16, 2021
A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primatesMaria Pino, Talha Abid, Susan Pereira Ribeiro, et al.
Research Square|January 4, 2022
The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamstersMichael Diamond, Peter Halfmann, Tadashi Maemura, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman PrimatesJoseph R Francica, Barbara J Flynn, Kathryn E Foulds, et al.
Science (New York, N.Y.)|September 16, 2021
Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primatesKizzmekia S Corbett, Martha C Nason, Britta Flach, et al.
Nature|January 21, 2022
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamstersPeter J Halfmann, Shun Iida, Kiyoko Iwatsuki-Horimoto, et al.
Science Translational Medicine|July 28, 2021
Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primatesJoseph R Francica, Barbara J Flynn, Kathryn E Foulds, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2021
Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman PrimatesKizzmekia S Corbett, Martha C Nason, Britta Flach, et al.
Science (New York, N.Y.)|August 13, 2021
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variantsAmarendra Pegu, Sarah E O'Connell, Stephen D Schmidt, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron VariantRajesh M Valanparambil, Jennifer Carlisle, Susanne L Linderman, et al.
Science Immunology|July 16, 2021
A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primatesMaria Pino, Talha Abid, Susan Pereira Ribeiro, et al.
Research Square|January 4, 2022
The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamstersMichael Diamond, Peter Halfmann, Tadashi Maemura, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman PrimatesJoseph R Francica, Barbara J Flynn, Kathryn E Foulds, et al.
Science (New York, N.Y.)|September 16, 2021
Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primatesKizzmekia S Corbett, Martha C Nason, Britta Flach, et al.
Nature|January 21, 2022
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamstersPeter J Halfmann, Shun Iida, Kiyoko Iwatsuki-Horimoto, et al.
Science Translational Medicine|July 28, 2021
Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primatesJoseph R Francica, Barbara J Flynn, Kathryn E Foulds, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2021
Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman PrimatesKizzmekia S Corbett, Martha C Nason, Britta Flach, et al.
Science (New York, N.Y.)|August 13, 2021
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variantsAmarendra Pegu, Sarah E O'Connell, Stephen D Schmidt, et al.
Pageof 4